Thiol-based NAALADase inhibitors

Details for Australian Patent Application No. 2002245271 (hide)

International Classifications

Event Publications

13 February 2003 Application Open to Public Inspection

Published as AU-B-2002245271

31 January 2008 Application Accepted

Published as AU-B-2002245271

29 May 2008 Standard Patent Sealed

19 February 2009 Assignment Registered

Guilford Pharmaceuticals Inc. The patent has been assigned to MGI GP, Inc.

26 March 2009 Assignment Registered

MGI GP, Inc. The patent has been assigned to Eisai Corporation of North America

10 December 2009 Assignment Registered

Eisai Corporation of North America The patent has been assigned to Eisai Inc.

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.